Tus kws kho mob
QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1391 - 1400 ntawm 4204
Tus kws kho mob
QP55-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP56-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Cibinqo™ (abrocitinib)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP57-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Pyrukynd® (mitapivat)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP58-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Recorlev® (levoketoconazole)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 13, 2022
Tus kws kho mob
upcoming-policies-effective-september-5_-2022.pdf
Tus kws kho mob
2022 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2022
Tus kws kho mob
P79R1-21 Notice of Admission (NOA) Claims Required for Home Care Claims Effective January 1, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2022